HK$54.85-17.39% · 3M
Moving avg
1W-6.24%
1M-6.16%
3M-16.58%
6M-21.92%
YTD-25.98%
1Y-30.83%
3Y-0.54%
5Y-0.54%
52-week range
$6.548% of range$12.13
Company health
Value0/6
Growth4/6
Profitability6/6
Health6/6
Dividend4/6
Bull vs bear
Strengths
- Strong 24% net margin
- High return on equity (1337%)
- Revenue compounding 13% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$46.39B
Enterprise value
$38.27B
P/E ratio (TTM)
42.74x
P/S ratio (TTM)
10.46x
EV/EBITDA
31.00x
Per share & returns
EPS (TTM)
$0.16
Dividend yield
0.37%
Beta (1Y)
0.12
30-day change
-6.16%
Trading
Volume (24h)
6.12M
Previous close
HK$56.05
Shares outstanding
6.64B
About Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
HKEX
Symbol
1276.HK
Jiangsu Hengrui Pharmaceuticals Co.,Ltd is a large-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry. Its shares are listed on HKEX (China) and trade under the ticker 1276.HK.
Frequently asked questions
What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's market cap?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK) has a market capitalization of $46.39B.
What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's P/E ratio?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd trades at a price-to-earnings (P/E) ratio of 42.74.
What exchange does 1276.HK trade on?
1276.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,221.17+0.07%
$1.15T cap
Johnson & JohnsonJNJ
$261.41+0.21%
$629.97B cap
AbbVie Inc.ABBV
$250.64+0.75%
$442.82B cap
UnitedHealth Group IncorporatedUNH
$403.30-0.56%
$366.25B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.71+1.34%
$332.70B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap